GPT and hepatocellular carcinoma: Additionally, in another small European study, Younes et al13 used noninvasive scoring systems (MASLD fibrosis score; FIB-4, BMI, AST/ALT ratio, and diabetes; and aspartate transaminase-platelet ratio index) and the Hepamet fibrosis score to risk stratify patients with MASLD for HCC risk and other liver outcomes.